DE EN

Select Research Group

Select Year

2007

The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib.

Hantschel O, Rix U, Schmidt U, Burckstummer T, Kneidinger M, Schutze G, Colinge J, Bennett KL, Ellmeier W, Valent P, Superti-Furga G.
Proc Natl Acad Sci USA. 2007, 104:13283–13288.
2007

CD14 facilitates invasive respiratory tract infections by Streptococcus pneumoniae.

Dessing M, Knapp S, Florquin S, de Vos AF, van der Poll T.
Am J Respir Crit Care Med. 2007, 175:604–611. 
2007

Introduction to computational proteomics.

Colinge J, Bennett KL.
PLoS Comput Biol 2007, 3:e114. 
2007

Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice.

Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB.
Arterioscl Thromb Vasc Biol. 2007, 27(5):1080–6. 
2007

Promise of immune modulation to inhibit atherogenesis.

Binder CJ, Hartvigsen K, Witztum JL.
J Am Coll Cardiol. 2007, 50(6):547–50.